Dr. Thad R. Denehy, MD

Dr. Denehy practices at Cooperman Barnabas Medical Center in Livingston, New Jersey, part of RWJBarnabas Health.

Dr. Denehy's NPI, 1912904756, was assigned on July 7, 2005. Dr. Denehy graduated from Wake Forest School of Medicine of Wake Forest Baptist Medical Center in 1984. Dr. Denehy holds New Jersey license 25MA04766500.

Dr. Denehy's primary practice is Cooperman Barnabas Medical Center, at 94 Old Short Hills Road, Livingston, NJ 07039 in Essex County. The practice phone is (973) 322-5000.

Dr. Denehy's primary practice is Cooperman Barnabas Medical Center in Livingston, New Jersey, part of RWJBarnabas Health. Dr. Denehy is also affiliated with Morristown Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Denehy to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denehy practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Denehy's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Denehy is licensed in New Jersey.

CMS data shows 392 Medicare services from Dr. Denehy across 12 procedure codes in 2024, for 192 Medicare patients. Medicare paid $61,713 for them.

CMS counts 192 Medicare patients who saw Dr. Denehy in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Denehy's median patient age at 54, with 94% women.

In 2024, Dr. Denehy wrote 217 Medicare Part D claims for 111 patients. 83% of them were for generic drugs. CMS names the drug for 128 of them, across 6 drugs with 11 or more claims each, at $12,390 in total drug cost. In 2023, CMS named 141 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Denehy for performance year 2024, reported through an alternative payment model (APM). Dr. Denehy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Denehy as offering telehealth. CMS counts 28 procedures of removal of the uterus by Dr. Denehy, more than 96% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Denehy. The most frequent topics are DNA Methylation, Endometrial Neoplasms and Microsatellite Instability. Dr. Denehy has published most often in Int J Gynecol Cancer. Dr. Denehy's most frequent co-authors are Robert R. Taylor, MD and Ruth Deborah Stephenson, DO.

CMS Open Payments shows 236 general payments to Dr. Denehy from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 44% of the total. Ethicon Inc. paid the most, $4,531.

Dr. Denehy graduated from Wake Forest School of Medicine of Wake Forest Baptist Medical Center in 1984.